Overactive bladder Trials in Birmingham, United States
Conditions / Overactive bladder / Birmingham, United States
Overactive bladder is a medical condition with active clinical research programs worldwide.
18 total trials for this combination
Showing top 10 of 18 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT02386072 | A Prospective, Observational, Multicenter Study of Patients Following Initiation of a New Course of Treatment for Overactive Bladder (OAB) | COMPLETED | — |
| NCT02660138 | Dysport® Treatment of Urinary Incontinence in Adults Subjects With Neurogenic Detrusor Overactivity (NDO) Due to Spinal Cord Injury or Multiple Sclerosis - Study 1 | TERMINATED | PHASE3 |
| NCT01302067 | A 12 Week Study to Confirm the Effectiveness of 8mg of Fesoterodine Compared to 4mg of Fesoterodine | COMPLETED | PHASE4 |
| NCT00350636 | A Comparison of a New Drug to Treat Overactive Bladder vs. Placebo | COMPLETED | PHASE3 |
| NCT03475706 | Evaluation of the Efficacy and Safety of Solabegron Tablets for Treatment of Overactive Bladder in Adult Women | COMPLETED | PHASE2 |
| NCT03492281 | A Study to Examine the Safety and Efficacy of a New Drug in Patients With Symptoms of Overactive Bladder (OAB) | COMPLETED | PHASE3 |
| NCT01868516 | Study Evaluating the Safety, Tolerability, and Efficacy of Dexmecamylamine (TC-5214) for Treatment of Overactive Bladder | COMPLETED | PHASE2 |
| NCT00928070 | A Study Of Efficacy And Safety Of Fesoterodine In Vulnerable Elderly Subjects With Overactive Bladder | COMPLETED | PHASE4 |
| NCT06511141 | Sacral Neuromodulation for Male Overactive Bladder (MOAB) | RECRUITING | — |
| NCT03149809 | Behavioral or Solifenacin Therapy for Urinary Symptoms in Parkinson Disease | COMPLETED | PHASE3 |